ES2135470T3 - Composiciones farmaceuticas y metodos que usan ibobutiramida para tratar trastornos de betaglobina. - Google Patents

Composiciones farmaceuticas y metodos que usan ibobutiramida para tratar trastornos de betaglobina.

Info

Publication number
ES2135470T3
ES2135470T3 ES93907532T ES93907532T ES2135470T3 ES 2135470 T3 ES2135470 T3 ES 2135470T3 ES 93907532 T ES93907532 T ES 93907532T ES 93907532 T ES93907532 T ES 93907532T ES 2135470 T3 ES2135470 T3 ES 2135470T3
Authority
ES
Spain
Prior art keywords
ibobutyramide
treat
methods
pharmaceutical compositions
betaglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93907532T
Other languages
English (en)
Inventor
Susan P Perrine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Childrens Hospital Medical Center
Childrens Hospital Oakland Research Center
Original Assignee
Cincinnati Childrens Hospital Medical Center
Childrens Hospital Oakland Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center, Childrens Hospital Oakland Research Center filed Critical Cincinnati Childrens Hospital Medical Center
Application granted granted Critical
Publication of ES2135470T3 publication Critical patent/ES2135470T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ESTA INVENCION SE REFIERE AL TRATAMIENTO DE LAS AFECCIONES DE LA BETAGLOBINA, COMO LA ANEMIA DE DEPRANOCITOS Y LA BETATALASANEMIA, MEDIANTE LA ADMINISTRACION DE COMPUESTOS DE ISOBUTIRAMIDA.
ES93907532T 1992-03-17 1993-03-17 Composiciones farmaceuticas y metodos que usan ibobutiramida para tratar trastornos de betaglobina. Expired - Lifetime ES2135470T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/852,511 US5439939A (en) 1992-03-17 1992-03-17 Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders

Publications (1)

Publication Number Publication Date
ES2135470T3 true ES2135470T3 (es) 1999-11-01

Family

ID=25313524

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93907532T Expired - Lifetime ES2135470T3 (es) 1992-03-17 1993-03-17 Composiciones farmaceuticas y metodos que usan ibobutiramida para tratar trastornos de betaglobina.

Country Status (10)

Country Link
US (1) US5439939A (es)
EP (1) EP0697862B1 (es)
AT (1) ATE181235T1 (es)
AU (1) AU3810693A (es)
DE (1) DE69325393T2 (es)
DK (1) DK0697862T3 (es)
ES (1) ES2135470T3 (es)
GR (1) GR3031241T3 (es)
SG (1) SG48764A1 (es)
WO (1) WO1993018761A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
IT1273628B (it) * 1993-06-04 1997-07-08 Emerging Pharmaceutical Techno Composizioni farmaceutiche per la cura della talassemia contenenti derivati dell'acido butirrico e in particolare isobutirramide
US5569675A (en) * 1994-03-07 1996-10-29 Bar Ilan University Methods of using carboxylic acid esters to increase fetal-hemoglobin levels
US5700640A (en) * 1994-09-16 1997-12-23 Basf Aktiengesellschaft Inducers of gamma globin gene expression and screening assays therefor
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
US6822267B1 (en) * 1997-08-20 2004-11-23 Advantest Corporation Signal transmission circuit, CMOS semiconductor device, and circuit board
CA2324426A1 (en) 1998-02-11 1999-08-19 Douglas V. Faller Compositions and methods for the treatment of cystic fibrosis
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
FR2847817B1 (fr) * 2002-11-28 2006-11-10 Centre Nat Rech Scient Utilisation d'un inhibiteur d'histone deacetylase pour le traitement des dystrophies musculaires
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
US20070042937A1 (en) * 2003-08-01 2007-02-22 Fibrogen, Inc. Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
JP2008524246A (ja) 2004-12-16 2008-07-10 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
JP2009501236A (ja) 2005-07-14 2009-01-15 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
US20070185045A1 (en) * 2006-02-06 2007-08-09 Ratcliffe Peter J Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
WO2011072086A1 (en) 2009-12-08 2011-06-16 Hemaquest Pharmaceuticals, Inc. Methods and low dose regimens for treating red blood cell disorders
US20110245154A1 (en) 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
WO2013119800A1 (en) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
WO2014144231A1 (en) 2013-03-15 2014-09-18 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
WO2016064815A1 (en) * 2014-10-20 2016-04-28 Massachusetts Institute Of Technology Functional ghrelin receptor antagonism during pregnancy to prevent stress-associated mental illness in offspring and mothers
WO2016138099A1 (en) 2015-02-24 2016-09-01 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
US20220226322A1 (en) 2019-05-31 2022-07-21 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors
MX2024004801A (es) 2021-10-19 2024-06-28 Akirabio Inc Composiciones que comprenden análogos de 2'- desoxicitidina, y uso de las mismas para el tratamiento de anemia de células falciformes, talasemia y cánceres.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482571A (en) * 1982-06-21 1984-11-13 University Of Pittsburgh Sickle cell anemia treatment and compound
US4822821A (en) * 1986-10-10 1989-04-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
US5025029A (en) * 1986-10-10 1991-06-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
SG86966A1 (en) * 1988-11-29 2002-03-19 Childrens Hosp Medical Center Medicament for augmenting fetal hemoglobin

Also Published As

Publication number Publication date
DE69325393D1 (de) 1999-07-22
ATE181235T1 (de) 1999-07-15
EP0697862A4 (en) 1996-05-29
AU3810693A (en) 1993-10-21
EP0697862B1 (en) 1999-06-16
DK0697862T3 (da) 1999-12-13
US5439939A (en) 1995-08-08
GR3031241T3 (en) 1999-12-31
EP0697862A1 (en) 1996-02-28
SG48764A1 (en) 1998-05-18
DE69325393T2 (de) 1999-12-16
WO1993018761A1 (en) 1993-09-30

Similar Documents

Publication Publication Date Title
ES2135470T3 (es) Composiciones farmaceuticas y metodos que usan ibobutiramida para tratar trastornos de betaglobina.
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
PT98905A (pt) Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem
GB0129260D0 (en) Pharmaceutical compositions and their uses
UA48939C2 (uk) Дизаміщені фуранони, способи їх одержання, фармацевтична композиція на їх основі, спосіб лікування запального захворювання, проміжні сполуки
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
NO303816B1 (no) Vandig retinoid-gelblanding
PT705100E (pt) Guanidinas substituidas terapeuticas
BRPI0114344B8 (pt) composto retinóide, seu uso, sua composição farmacêutica e seu processo de preparação
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
BR0308957A (pt) Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
ES2144054T3 (es) Complejos de tri(platino).
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
DE68912022D1 (de) Reizvermeidende und desensibilisierende Zusammensetzungen und Verfahren zu deren Anwendung.
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
ID26240A (id) Formulasi obat setengah padat yang mengandung dekstoprofen trometamol
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
MX9307048A (es) Derivados de piridazinoquinazolona, y composicion farmaceutica que los contiene.
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
ATE242766T1 (de) Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen
AU2003266031A1 (en) Pomolic acid, its isomers, derivatives and their uses, pharmaceutical composition method to prepare the pharmaceutical composition and method for treating multidrug resistant tumours

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 697862

Country of ref document: ES